197A — TAUNS Laboratories Balance Sheet
0.000.00%
Last trade - 00:00- ¥51bn
- ¥50bn
- ¥16bn
- 26
- 42
- 50
- 30
Annual balance sheet for TAUNS Laboratories, fiscal year end - June 30th, JPY millions except per share, conversion factor applied.
2022 June 30th | 2023 June 30th | |
|---|---|---|
| Period Length: | — | — |
| Source: | PROSPECTUS | PROSPECTUS |
| Standards: | JAS | JAS |
| Status: | Final | Final |
| Cash and Equivalents | ||
| Cash and Short Term Investments | 6,347 | 1,244 |
| Net Total Accounts Receivable | ||
| Net Total Receivables | 942 | 3,481 |
| Total Inventory | ||
| Prepaid Expenses | ||
| Total Other Current Assets | ||
| Total Current Assets | 12,036 | 9,457 |
| Gross Property, Plant And Equipment | ||
| Accumulated Depreciation | ||
| Net Property, Plant And Equipment | 3,683 | 4,402 |
| Net Intangible Assets | ||
| Long Term Investments | ||
| Long Term Notes Receivable | ||
| Other Long Term Assets | ||
| Total Assets | 20,268 | 18,332 |
| Accounts Payable | ||
| Accrued Expenses | ||
| Notes Payable / Short Term Debt | ||
| Current Portion of Long Term Debt / Capital Leases | ||
| Total Other Current Liabilities | ||
| Total Current Liabilities | 8,937 | 6,518 |
| Long Term Debt | ||
| Total Long Term Debt | ||
| Total Debt | ||
| Deferred Income Tax | ||
| Total Other Liabilities | ||
| Total Funded Status | ||
| Total Liabilities | 12,912 | 9,842 |
| Common Stock | ||
| Additional Paid In Capital | ||
| Retained Earnings (Accumulated Deficit) | ||
| Unrealized Gain / Loss | ||
| Total Equity | 7,356 | 8,490 |
| Total Liabilities & Shareholders' Equity | 20,268 | 18,332 |
| Total Common Shares Outstanding |